Evidence-driven AI coronary plaque analysis - Autoplaque
100
peer-reviewedpublications
35
Academicsites
The Landmark SCOT-HEART clinical trial
RAPID-CTCA, NXT, PACIFIC, PREFFIR, DIAMOND, EVOLVE, LodoCo 2, WARRIOR


Patients with larger total plaque volume and low-attenuation plaque burden are several fold likely to have subsequent heart attack.
Low-Attenuation NCP >4%: HR 4.65; 95% CI, 2.06-10.5; p<0.001
Williams,..., Newby, Dweck, Dey at al Circulation 2020

ICC 0.922

ICC 0.95


2803 patients, international
multicenter study

